TGA to review diabetes drug

The Therapeutic Goods Administration is reviewing new research linking bladder cancer with the use of the diabetes drug pioglitazone. A TGA spokesperson said the organisation had previously advised health professionals and consumers about the potential risk through alerts and articles on its websites, and was aware of the new research. “The TGA will review the information ...

Already a member?

Login to keep reading.

© 2021 the limbic